9-9 | The medical humanitarian organisation Médecins Sans Frontières (MSF) is deeply concerned about the implications of the current economic crisis in Swaziland on people living with HIV/AIDS. To pre-empt stock ruptures, which are already affecting patients, MSF has supplied a contingency stock of antiretroviral (ARV) drugs that will serve some 18,000 AIDS patients in its project areas for at least one month.
8-17 | Hadija Isaac ABDU toys with the plastic syringe that she uses to feed her severely malnourished three-year-old son at the MSF stabilisation centre in Malkadida refugee camp. “We are farmers; we grow corn and sorghum. We had cows. The crops failed because of the drought and when the cattle died we decided to leave. We had to walk for seven days without food to get here. The only food we ate was what people gave us along the way.”
7-12 | Excluded countries should be ready to issue compulsory licences to access needed drugs An agreement announced today by pharmaceutical company Gilead to licence several HIV/AIDS drugs to the Medicines Patent Pool could improve access to medicines for patients, but excludes several countries with large numbers of people living with HIV, the international medical humanitarian organisation Médecins Sans Frontières (MSF) said today.
6-30 | Libya: Aid on the frontlineHaiti: resurgence of choleraJapan: Survivor traumaHIV/AIDS: ARVs for 15 millions patientsFrance: Dangerous amendments
6-9 | Funds and affordable drugs needed to turn target into treatment On the heels of new evidence that shows HIV treatment is also HIV prevention, governments meeting at a UN Summit on AIDS have taken a critical step by committing to reach 15 million people with HIV treatment by 2015 – but they must take immediate concrete action to make this treatment target a reality, the international medical humanitarian organization Médecins Sans Frontières (MSF) said today.